Search

Your search keyword '"Olga Barbarash"' showing total 486 results

Search Constraints

Start Over You searched for: Author "Olga Barbarash" Remove constraint Author: "Olga Barbarash"
486 results on '"Olga Barbarash"'

Search Results

1. Frailty as an Independent Predictor of Adverse Outcomes in Patients Undergoing Direct Myocardial Revascularization

2. Proteomic Profiling of Endothelial Cells Exposed to Mitomycin C: Key Proteins and Pathways Underlying Genotoxic Stress-Induced Endothelial Dysfunction

3. Urbanization and physical activity in the global Prospective Urban and Rural Epidemiology study

4. Cognitive functions and patterns of brain activity in patients after simultaneous coronary and carotid artery revascularization

5. A Comparison of Two Multi-Tasking Approaches to Cognitive Training in Cardiac Surgery Patients

6. The Role of Polymorphism in the Endothelial Homeostasis and Vitamin D Metabolism Genes in the Severity of Coronary Artery Disease

7. Association of body mass index with outcomes in patients with newly diagnosed atrial fibrillation: GARFIELD-AF

8. Expression of Ceramide-Metabolizing Enzymes in the Heart Adipose Tissue of Cardiovascular Disease Patients

9. Genetic forms and pathophysiology of essential arterial hypertension in minor indigenous peoples of Russia

10. Effect of Carotid Stenosis Severity on Patterns of Brain Activity in Patients after Cardiac Surgery

11. A Nationwide pilot project to develop rehabilitation services for patients with cardiovascular diseases

12. Randomized Clinical Trial of Surgical vs. Percutaneous vs. Hybrid Revascularization in Multivessel Coronary Artery Disease: Residual Myocardial Ischemia and Clinical Outcomes at One Year—Hybrid coronary REvascularization Versus Stenting or Surgery (HREVS)

13. Localization of fat depots and cardiovascular risk

14. A comparison of the genetic and clinical risk factors for arterial hypertension between indigenous and non-indigenous people of the Shoria Mountain Region

15. Relationships between epicardial adipose tissue thickness and adipo-fibrokine indicator profiles post-myocardial infarction

16. Biochemical markers of type 2 diabetes as a late complication of myocardial infarction: a case-control study

17. Adipocytes Directly Affect Coronary Artery Disease Pathogenesis via Induction of Adipokine and Cytokine Imbalances

18. Relationship between epicardial and perivascular fatty tissue and adipokine-cytokine level in coronary artery disease patients.

19. Serum and Echocardiographic Markers May Synergistically Predict Adverse Cardiac Remodeling after ST-Segment Elevation Myocardial Infarction in Patients with Preserved Ejection Fraction

20. The management of acute myocardial infarction in the Russian Federation: protocol for a study of patient pathways [version 2; referees: 2 approved]

21. Serum neutrophil gelatinase-associated lipocalin the estimation of hospital prognosis in patients with ST-elevated myocardial infarction.

22. Increased Serum Parathyroid Hormone, Osteocalcin and Alkaline Phosphatase Are Associated with a Long-Term Adverse Cardiovascular Outcome after Coronary Artery Bypass Graft Surgery

23. Early Effects of Treatment Low-dose Atorvastatin on Markers of Insulin Resistance and Inflammation in Patients with Myocardial Infarction

24. Endovascular Interventions Permit Isolation of Endothelial Colony-Forming Cells from Peripheral Blood

25. Kidney and Cardiovascular Effects of Canagliflozin According to Age and Sex

26. 36-month clinical outcomes of patients with venous thromboembolism

27. Association of the triglyceride glucose index as a measure of insulin resistance with mortality and cardiovascular disease in populations from five continents (PURE study): a prospective cohort study

28. GARFIELD-AF: risk profiles, treatment patterns and 2-year outcomes in patients with atrial fibrillation in Germany, Austria and Switzerland (DACH) compared to 32 countries in other regions worldwide

29. Eurasian clinical guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndrome (NSTE-ACS)

30. Role of comorbidity in assessment of long-term prognosis after myocardial infarction

31. Ethnicity as a model for the development of cardiovascular diseases and their risk factors in epidemiological studies

32. Serum markers of cardiac fibrosis suffering from heart failure with preserved left ventricular ejection fraction upon ST-segment elevation myocardial infarction

33. Eurasian Guidelines for the diagnostics and management of stable coronary artery disease (2020-2021)

34. Inflammation and Comorbidity. Are There any Chances to Improve the Prognosis in Patients with Extremely High Cardiovascular Risk?

35. Features of clinical and anamnestic characteristics and treatment of patients with hypertriglyceridemia (the data from Kuzbass register of dyslipidemias)

36. Clinical and anamnestic characteristics of patients with an implanted cardioverter-defibrillator in real clinical practice (data from the Kuzbass register)

37. Changes in Cardiovascular Risk Factors in Residents of the Siberian Region (According to Epidemiological Studies)

38. Prevalence of Musculoskeletal Disorders in Patients with Coronary Artery Disease

39. Thrombolytic Therapy in Treatment in Patients with Pulmonary Embolism not High-risk: SIRENA Registry Data

40. Elderly patient with coronary artery disease. What are common problems that need solving?

41. The necessity and timing of smoking cessation before scheduled cardiovascular interventions – doctors' survey

42. Association of smoking with coronary artery disease depending on other cardiovascular risk factors

43. The resolution on empagliflozin and heart failure has been adopted by the experts of the Siberian Federal District based on the results of the EMPEROR-Reduced study

44. IL18-family Genes Polymorphism Is Associated with the Risk of Myocardial Infarction and IL18 Concentration in Patients with Coronary Artery Disease

45. Impact of short-term physical prehabilitation on psychophysiological parameters in patients undergoing coronary artery bypass grafting

48. Frailty syndrome in patients with coronary artery disease

49. The relationship of the epicardial fat and adipo-fibrokines in myocardial infarction

50. Cardiovascular Comorbidity: Patient with Coronary Artery Disease and Peripheral Artery Atherosclerosis. How to Identify and Manage the Risks of Ischemic Events?

Catalog

Books, media, physical & digital resources